Marcellusi A, Bini C, Corinti S, et al. [Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]. Farmeconomia. Health Economics and Therapeutic Pathways. 2023;24(1). https://doi.org/10.7175/fe.v24i1.1548